Insulet Corp. (PODD): Price and Financial Metrics

Insulet Corp. (PODD): $285.56

1.49 (+0.52%)

POWR Rating

Component Grades








Add PODD to Watchlist
Sign Up

PODD Price/Volume Stats

Current price $285.56 52-week high $335.91
Prev. close $284.07 52-week low $192.33
Day low $281.14 Volume 543,700
Day high $285.80 Avg. volume 725,717
50-day MA $310.43 Dividend yield N/A
200-day MA $286.74 Market Cap 19.90B

PODD Stock Price Chart Interactive Chart >


  • PODD scores best on the Growth dimension, with a Growth rank ahead of 86.08% of US stocks.
  • PODD's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • PODD's current lowest rank is in the Momentum metric (where it is better than 6.83% of US stocks).

PODD Stock Summary

  • PODD's current price/earnings ratio is 34,121.92, which is higher than 100% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for PODD is currently 153.7, higher than 97.81% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 14.97, INSULET CORP has a higher such ratio than 92.76% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to INSULET CORP are INDT, CATO, LEV, RMNI, and OWL.
  • Visit PODD's SEC page to see the company's official filings. To visit the company's web site, go to

PODD Valuation Summary

  • PODD's EV/EBIT ratio is 830.8; this is 6823.33% higher than that of the median Healthcare stock.
  • PODD's price/earnings ratio has moved up 34444.1 over the prior 195 months.

Below are key valuation metrics over time for PODD.

Stock Date P/S P/B P/E EV/EBIT
PODD 2023-05-23 15.1 41.1 34433.2 830.8
PODD 2023-05-22 15.6 42.5 35608.8 858.2
PODD 2023-05-19 15.3 41.7 34967.5 843.3
PODD 2023-05-18 15.4 42.0 35181.3 848.2
PODD 2023-05-17 16.0 43.4 36376.5 876.0
PODD 2023-05-16 16.3 44.3 37156.0 894.2

PODD Growth Metrics

    The year over year net cashflow from operations growth rate now stands at -188.95%.
  • Its 5 year revenue growth rate is now at 100.43%.
  • Its 2 year net cashflow from operations growth rate is now at -152.81%.
PODD's revenue has moved up $268,100,000 over the prior 15 months.

The table below shows PODD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,305.3 119 4.6
2022-09-30 1,243.3 42.8 16.8
2022-06-30 1,178.1 -39.7 34.6
2022-03-31 1,141.9 -46.7 44.6
2021-12-31 1,098.8 -68.1 16.8
2021-09-30 1,037.2 -43.6 -29.5

PODD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PODD has a Quality Grade of C, ranking ahead of 61.86% of graded US stocks.
  • PODD's asset turnover comes in at 0.542 -- ranking 84th of 186 Medical Equipment stocks.
  • UFPT, NEPH, and NSPR are the stocks whose asset turnover ratios are most correlated with PODD.

The table below shows PODD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.542 0.666 0.011
2021-03-31 0.544 0.650 0.036
2020-12-31 0.573 0.644 0.034
2020-09-30 0.621 0.640 0.049
2020-06-30 0.642 0.638 0.040
2020-03-31 0.691 0.644 0.029

PODD Price Target

For more insight on analysts targets of PODD, see our PODD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $290.41 Average Broker Recommendation 1.6 (Moderate Buy)

Insulet Corp. (PODD) Company Bio

A medical device company developing and marketing insulin infusion system. (Source:Wiki)

PODD Latest News Stream

Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream

Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about INSULET CORP that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Insiders Pour Millions Into These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Pay Attention

Savvy investors will always be looking to pick up shares of undervalued stocks. That is, after all, the essence behind the slogan ‘buy low, sell high.’ The problem, though, lies in determining which stocks are merely temporarily languishing in the doldrums and are primed to pick up steam, rather than indicating that their depressed prices are just not worth the time of day. Of course, there are many ways to assess that scenario, and one simple strategy is to examine the actions taken by insiders

Yahoo | May 29, 2023

Here's Why You Should Retain Insulet (PODD) Stock for Now

Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.

Yahoo | May 23, 2023

HAE or PODD: Which Is the Better Value Stock Right Now?

HAE vs. PODD: Which Stock Is the Better Value Option?

Yahoo | May 22, 2023

Insulet (NASDAQ:PODD) shareholder returns have been splendid, earning 271% in 5 years

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

Yahoo | May 15, 2023

The Petri Dish: Laronde CEO exits after 6 months; Enanta seeks Covid pill partner

Finch Therapeutics forges a path forward, Insulet shakes up its C-suite, plus other biotech news in the Petri Dish.

Yahoo | May 11, 2023

Read More 'PODD' Stories Here

PODD Price Returns

1-mo -13.14%
3-mo -0.21%
6-mo -5.86%
1-year 34.69%
3-year 59.50%
5-year 203.72%
YTD -3.00%
2022 10.64%
2021 4.08%
2020 49.32%
2019 115.83%
2018 14.96%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!